| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/21/2002 | US20020034731 Classifying tissue sample; obtain sample, separate onto substrate segments, expose to modulators and analyze activity of segments |
| 03/21/2002 | US20020034730 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 03/21/2002 | US20020034729 Detecting active metabolites in sample; incubate drug with microsomal enzyme, mix glutathione, detect glutathione conjugate |
| 03/21/2002 | US20020034728 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 03/21/2002 | US20020034727 Evaluation of mucus sample; obtain mucus, centrifuge, separate and measure pellet |
| 03/21/2002 | US20020034725 Sensitization of cells to radiation and and chemotherapy |
| 03/21/2002 | US20020034475 Ingestibles possessing intrinsic color change |
| 03/21/2002 | US20020034457 Fluorescent binding analysis |
| 03/21/2002 | US20020034211 Method and apparatus for the nondestructive determination of the purity of precious metals and the composition of an unknown material sample |
| 03/21/2002 | US20020033939 Instrument for selecting and depositing multicellular organisms and other large objects |
| 03/21/2002 | US20020033874 Thermal printhead with memory |
| 03/21/2002 | US20020033704 Cotton moisture meter |
| 03/21/2002 | US20020033370 Extracorporeal blood processing methods and apparatus |
| 03/21/2002 | US20020033345 Detection electron transferring; redox system |
| 03/21/2002 | US20020033337 Bulk fluid flow; electrophoresis separation |
| 03/21/2002 | US20020033125 Method of firebox temperature control for achieving carbon monoxide emission compliance in industrial furnaces with minimal energy consumption |
| 03/21/2002 | US20020033058 Obtention and analysis of odors from odor emitters |
| 03/21/2002 | US20020033053 Method of evaluating high fatigue strength material in high tensile strength steel and creation of high fatigue strength material |
| 03/21/2002 | DE10135448A1 Liquid degredation detection device, has liquid fed through flow channel configured for gradual blockage by soil components |
| 03/21/2002 | DE10115307C1 Ground soil sampling device has inner part of front point retracted inwards at required sampling position for extraction of soil plug |
| 03/21/2002 | DE10046187A1 Verfahren zur Messung der Aktivität von Gerinnungsfaktor XIIIa A method for measuring the activity of coagulation factor XIIIa |
| 03/21/2002 | DE10044648A1 Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material Method of replication or removal of Cirocoviren from biological material |
| 03/21/2002 | DE10044639A1 Indirektes Verfahren zur quantitativen Bestimmung der freien Bindungskapazität in einer wäßrigen Proteinlösung Indirect method for quantitatively determining the binding free capacity in an aqueous protein solution |
| 03/21/2002 | DE10044634A1 Indirektes Verfahren zur quantitativen Bestimmung der vorhandenen Bindungskapazität in einer wäßrigen Proteinlösung Indirect method for quantitatively determining the binding capacity present in an aqueous protein solution |
| 03/21/2002 | DE10044373A1 Neues Reagenz zur Markierung von Nukleinsäuren A new reagent for the labeling of nucleic acids |
| 03/21/2002 | DE10041988A1 Novel device for measuring forces exerted by living material, useful e.g. for identifying potential therapeutic agents that alter such forces |
| 03/21/2002 | DE10041596A1 Vorrichtung und Verfahren zum ortsaufgelösten Untersuchen vernetzter Zellen und/oder Zellsystemen und Verwendung für die Wirkstoffuntersuchung Apparatus and method for spatially resolved examining cross-linked cells and / or cell systems and use in drug investigation |
| 03/21/2002 | CA2703141A1 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in situ analysis |
| 03/21/2002 | CA2585083A1 Directed evolution method |
| 03/21/2002 | CA2460001A1 Diagnostic assay |
| 03/21/2002 | CA2452023A1 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample |
| 03/21/2002 | CA2426517A1 Methods and compositions for glycosidase assays |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422815A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/21/2002 | CA2422762A1 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422320A1 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422122A1 A system and method for identifying t cell and other epitopes and the like |
| 03/21/2002 | CA2422110A1 Method and apparatus for gradient generation |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422068A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | CA2422010A1 Test strips for detecting the presence of a reduced cofactor in a sample and methods for using the same |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421963A1 Directed evolution method |
| 03/21/2002 | CA2421938A1 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421582A1 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2419244A1 System and method for optimizing drug therapy for the treatment of diseases |
| 03/21/2002 | CA2419154A1 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 03/21/2002 | CA2418724A1 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/20/2002 | EP1189281A2 Chip-arrangement |
| 03/20/2002 | EP1189064A1 Method for controlling the useability of analytical elements |
| 03/20/2002 | EP1189063A1 Method for detecting PSA and its molecular forms using thiophilic gel |
| 03/20/2002 | EP1189062A1 Method and device for identifying molecular species |
| 03/20/2002 | EP1189061A1 Multifunctional erythrocyte reagent containing carbamates and uses |
| 03/20/2002 | EP1189060A1 Diagnostic assays for Alzheimer's disease using phosphoprotein PEA-15 |
| 03/20/2002 | EP1189059A1 Blood cell detector, blood analyzer and blood analyzing method using the detector |
| 03/20/2002 | EP1189057A2 Method and device for the determination of features by analysis of human or animal biological samples |
| 03/20/2002 | EP1189053A1 Method of detecting streaks in a moving paper web |
| 03/20/2002 | EP1189051A1 Compression tester |
| 03/20/2002 | EP1188987A2 Method for controlling the temperature in incineration plants |
| 03/20/2002 | EP1188839A1 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 03/20/2002 | EP1188769A2 High resolution crystal structure of the ribosome and design of protein synthesis inhibitors |
| 03/20/2002 | EP1188531A2 Resin recycling system |
| 03/20/2002 | EP1188483A2 Container for holding biological liquids for analysis |
| 03/20/2002 | EP1188482A2 Apparatus & method for conducting assays |
| 03/20/2002 | EP1188060A1 Method and apparatus for presenting thrombosis and hemostasis assay data |
| 03/20/2002 | EP1188059A2 Enumeration method of analyte detection |
| 03/20/2002 | EP1188058A2 Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith |
| 03/20/2002 | EP1188057A2 Incorporation and appliations of biomolecular interactions within a carrier |
| 03/20/2002 | EP1188056A1 Use of gabapentin in assays to identify gabab receptor modulators |
| 03/20/2002 | EP1188055A2 Laboratory examination of a body fluid or tissue sample |
| 03/20/2002 | EP1188054A2 Method and device for measuring organic and inorganic accompanying substances in a flat item |
| 03/20/2002 | EP1188053A1 Device for measuring a carbon monoxide content |
| 03/20/2002 | EP1188049A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 03/20/2002 | EP1188045A1 Method of diagnosing colorectal adenomas and cancer using proton magnetic resonance spectroscopy |
| 03/20/2002 | EP1188043A1 Method and device for detecting foreign matter in a fibre composite moving in the longitudinal direction |
| 03/20/2002 | EP1188042A1 Method and device for identifying a polymer |
| 03/20/2002 | EP1188040A1 Method and device for determining the thermal-oxidative load state of fats and oils |
| 03/20/2002 | EP1187939A2 Detection of hiv-1 by nucleic acid amplification |
| 03/20/2002 | EP1187936A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 03/20/2002 | EP1187935A2 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
| 03/20/2002 | EP1187934A1 Cell-based assay for screening cox-2 inhibitors |
| 03/20/2002 | EP1187933A1 Method and kit for detecting betalactam-containing compounds |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187928A2 Virus like particles, preparation and use in screening and functional genomics |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |